Cargando…
Adalimumab Mitigates Lumbar Radiculopathy in a Case of Ankylosing Spondylitis
Patient: Male, 46-year-old Final Diagnosis: Ankylosing spondylitis Symptoms: Low back pain Medication:— Clinical Procedure: — Specialty: Rehabilitation • Rheumatology OBJECTIVE: Rare coexistence of disease or pathology BACKGROUND: Ankylosing spondylitis (AS) is an immune-mediated chronic inflammator...
Autores principales: | Persaud, Trevor, Morgan, Richard, Thant, Hein Linn, DeAsis, Francis J., Ferre, Felix, Diaz, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253855/ https://www.ncbi.nlm.nih.gov/pubmed/35776690 http://dx.doi.org/10.12659/AJCR.936600 |
Ejemplares similares
-
Efficacy and safety of adalimumab in ankylosing spondylitis
por: Mounach, Aziza, et al.
Publicado: (2014) -
Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis
por: Chen, Zena, et al.
Publicado: (2021) -
Early Adalimumab and Anti‐Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients
por: Ding, Xiaoliang, et al.
Publicado: (2020) -
Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy
por: Hennigan, Stephanie, et al.
Publicado: (2007) -
Palmoplantar Pustulosis Induced by both Adalimumab and Golimumab for Treatment of Ankylosing Spondylitis
por: Seol, Jung Eun, et al.
Publicado: (2016)